JUN 07, 2018 07:00 AM PDT

How microCT Can Provide Insight into Dynamic Disease Processes

SPONSORED BY: Bruker
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Assistant Professor, KU Leuven
    Biography
      Greetje Vande Velde is an Assistant Professor in Imaging and Pathology at The KU Leuven (University of Leuven). Since completing her Ph.D. at KU Leuven, Greetje has held multiple research positions within and outside the university, and has published over 60 journal papers focused around imaging lung diseases and infections.

    Abstract:
    DATE: June 7, 2018
    TIME: 07:00AM PDT, 4:00PM CEST
     
     
    In this webinar, Professor Greetje Vande Velde will give an overview of her work, which involves lung and brain infections.  Professor Vande Velde will describe how high-field MRI and low dose microCT complement each other; where microCT gives high contrast in the lungs and MRI allows clear visualization of the brain. 
     
    The webinar will also introduce the use of the Skyscan 1278 microCT from Bruker, that was used in Professor Vande Velde’s experiments, as is a non-invasive imaging technique that can be used with the same animal multiple times - to not only create high quality images, but to also minimize the number of animals used in the trials.
     
    What to expect:
    This webinar will look at how non-invasive imaging can yield much better results at the preclinical stage and how the ethics of preclinical research can also be improved. Expect to see how the Skyscan 1278 microCT in combination with a BioSpec 9.4 T MRI can be used to improve the data generated from animals, regardless of the species or disease type. Viewers should also expect to see the many benefits this technique offers, as well as the types of disease that it is useful for.
     
     
    Key topics:
    Introduction to Micro CT
    Benefits:
    • Data Processing (better and more relevant data)
    • Higher Image Quality
    • Ability to Image an animal multiple times
    • High spatial & temporal resolution
    • Low radiation dosage
    • Improved preclinical workflow
     
    Combining CT with MRI
    Applications:
    • Lung disease
    • Cardiac disease
    • Metabolic diseases
    • Cancerous tumors
    • Brain imaging
    • Animal disease model phenotyping
     
    Improving Ethics:
    Reducing the number of (transgenic) animals used in preclinical research/studies
    • Non-invasive
     
    Who should attend?
    The webinar is primarily aimed at those who work with animals, in particular transgenic animals, and are looking to refine and reduce, or improve their workflow. Additionally, people who are involved in lung, cardiac and neuroscience research would find this webinar useful.

    Show Resources
    You May Also Like
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...